Conséquences cardiovasculaires de la mort cérébrale et prise en charge pour prélèvement d’organe(s)

Linden PK (2009) History of solid organ transplantation and organ donation. Crit Care Clin 25:165–84 Lamy F-X, Atinault A, Thuong M (2013) Organ procurement in France: new challenges. Press Med 42:295–308 Guerrini P, Claquin J (2006) Pénurie d’organes et de tissus en France. Press Med 35:1603–10 Conférence d’experts SFAR 1998 (1999) Texte court. Réanimation du sujet en état de mort encéphalique en vue de prélèvements d’organes. Ann Fr Anesth Reanim 18:4–12 Boulard G, Guiot P, Pottecher T, Tenaillon A (2005) Management of subjects in a state of brain death and the preservation of organs. Ann Fr Anesth Reanim 24:836–43 Agence de la Biomédecine (2010) Livret d’aide à la prise en charge d’un donneur potentiel d’organes en vue de prélèvement. Disponible sur: http://www.agence-biomedecine.fr/IMG/pdf/livret_aidebd.pdf (page consultée le 08/01/2015) Pinsard M, Ketforme T, Mimoz O (2013) Conséquences de la mort encéphalique et réanimation du donneur d’organes. Conférences d’actualisation. Congrès SFAR. Pages 1–14. Disponible sur: http://www.sfar.org/_docs/actas_2013/2013_med_confactu_12_Pinsard.pdf (page consultée le 08/01/2015) Guiot P, Cheisson G, Delabranche X, Charpentier J (2007) Optimisation hémodynamique des donneurs potentiels en état de mort encéphalique. Réanimation 16:149–55 Riou B (2004) Critères de prélèvement d’organes et réanimation du patient en état de mort encéphalique. EMC Médecine 1:229–41 Wood KE, Becker BN, McCartney JG, et al (2004) Care of the potential organ donor. N Engl J Med 351:2730–9 McKeown DW, Bonser RS, Kellum JA (2012) Management of the heartbeating brain-dead organ donor. Br J Anaesth 108:i96–107 Kutsogiannis DJ, Pagliarello G, Doig C, et al (2006) Medical management to optimize donor organ potential: review of the literature. Can J Anaesth 53:820–30 Dictus C, Vienenkoetter B, Esmaeilzadeh M, et al (2009) Critical care management of potential organ donors: our current standard. Clin Transplant 23(Suppl 21):2–9 Zaroff JG, Rosengard BR, Armstrong WF, et al (2002) Consensus Conference Report: Maximizing Use of Organs Recovered From the Cadaver Donor: Cardiac Recommendations. Circulation 106:836–41 Shemie SD, Ross H, Pagliarello J, et al (2006) Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ 174: S13–32 Smith M (2004) Physiologic changes during brain stem death- lessons for management of the organ donor. J Heart Lung Transplant 23:S217–S22 Mertes PM, Audibert G (2004) Physiopathologie de la mort encéphalique. Le Praticien en anesthésie réanimation 8:275–80 Chen EP, Bittner HB, Kendall SW, Van Trigt P (1996) Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 24:1352–9 Shivalkar B, Van Loon J, Wieland W, et al (1993) Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 87:230–9 Fodstad H, Kelly PJ, Buchfelder M (2006) History of the cushing reflex. Neurosurgery 59:1132–7 Audibert G, Charpentier C, Seguin-Devaux C, et al (2006) Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 82:1031–6 Avlonitis VS, Wigfield CH, Kirby JA, Dark JH (2005) The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 5:684–93 Adrie C, Monchi M, Fulgencio JP, et al (2010) Immune status and apoptosis activation during brain death. Shock 33:353–62 Birks EJ, Yacoub MH, Burton PS, et al (2000) Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation 70:1498–506 Danobeitia JS, Sperger JM, Hanson MS, et al (2012) Early activation of the inflammatory response in the liver of brain-dead non-human primates. J Surg Res 176:639–48 van der Hoeven JA, Horst Ter GJ, Molema G, et al (2000) Effects of Brain Death and Hemodynamic Status on Function and Immunologic Activation of the Potential Donor Liver in the Rat. Ann Surg 232:804–13 van der Hoeven JA, Molema G, Horst Ter GJ, et al (2003) Relationship between duration of brain death and hemodynamic (in) stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 64:1874–82 Murugan R, Venkataraman R, Wahed AS, et al (2008) Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med 36:1810–6 Weiss S, Kotsch K, Francuski M, et al (2007) Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 7:1584–93 Dikdan GS, Mora-Esteves C, Koneru B (2012) Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues. Transplantation 94:425–41 Dupuis S, Amiel JA, Desgroseilliers M, et al (2014) Corticosteroids in the management of brain-dead potential organ donors: a systematic review. Br J Anaesth 113:346–59 Masson F, Thicoïpe M, Latapie MJ, Maurette P (1990) Thyroid function in brain-dead donors. Transplant Int 3:226–33 Nicolas-Robin A, Barouk JD, Amour J, et al (2010) Hydrocortisone supplementation enhances hemodynamic stability in braindead patients. Anesthesiology 112:1204–10 Goudreau JL, Wijdicks EF, Emery SF (2000) Complications during apnea testing in the determination of brain death: Predisposing factors. Neurology 55:1045–8 Casartelli M, Bombardini T, Simion D, et al (2012) Wait, treat and see: echocardiographic monitoring of brain-dead potential donors with stunned heart. Cardiovasc Ultrasound 10:25 Dujardin KS, McCully RB, Wijdicks EFM, et al (2001) Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 20:350–7 Venkateswaran RV, Townend JN, Wilson IC, et al (2010) Echocardiography in the potential heart donor. Transplantation 89:894–901 Khush KK, Menza R, Nguyen J, et al (2012) Electrocardiographic characteristics of potential organ donors and associations with cardiac allograft use. Circ Heart Fail 5:475–83 McLean KM, Pandalai PK, Pearl JM, et al (2007) Betaadrenergic receptor antagonism preserves myocardial function after brain death in a porcine model. J Heart Lung Transplant 26:522–8 Pandalai PK, McLean KM, Bulcao CF, et al (2008) Acute betablockade prevents myocardial beta-adrenergic receptor desensitization and preserves early ventricular function after brain death. J Thorac Cardiovasc Surg 135:792–8 Ferrera R, Hadour G, Tamion F, et al (2011) Brain death provokes very acute alteration in myocardial morphology detected by echocardiography: preventive effect of beta-blockers. Transplant Int 24:300–6 Novitzky D, Cooper DK (2014) Thyroid hormone and the stunned myocardium. J Endocrinol 223:R1–8 Novitzky D, Cooper DK, Rosendale JD, Kauffman HM (2006) Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 82:1396–401 Riou B, Kalfon P, Arock M, et al (1995) Cardiovascular consequences of severe hypophosphataemia in brain-dead patients. Br J Anaesth 74:424–9 Fulgenico JP, Riou B, Devilliers C, et al (1995) Plasma ionized calcium in brain-dead patients. Intensive Care Med 21:832–7 Szabó G (2004) Physiologic changes after brain death. J Heart Lung Transplant 23:S223–6 Murugan R, Venkataraman R, Wahed AS, et al (2009) Preload responsiveness is associated with increased interleukin-6 and lower organ yield from brain-dead donors. Crit Care Med 37:2387–93 Vincent JL, De Backer D (2013) Circulatory shock. N Engl J Med 369:1726–34 Langeron O, Couture P, Mateo J, et al (1996) Oxygen consumption and delivery relationship in brain-dead organ donors. Br J Anaesth 76:783–9 Nicolas-Robin A, Barouk JD, Darnal E, et al (2011) Free cortisol and accuracy of total cortisol measurements in the diagnosis of adrenal insufficiency in brain-dead patients. Anesthesiology 115:568–74 Cinotti R, Roquilly A, Mahé PJ, et al (2014) Pulse pressure variations to guide fluid therapy in donors: a multicentric echocardiographic observational study. J Crit Care 29:489–94 Nicolas-Robin A, Salvi N, Medimagh S, et al (2007) Combined measurements of N-terminal pro-brain natriuretic peptide and cardiac troponins in potential organ donors. Intensive Care Med 33:986–92 Al-Khafaji A, Elder M, Lebovitz DJ, et al (2015) Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med 41:418–26 Venkateswaran RV, Dronavalli V, Patchell V, et al (2013) Measurement of extravascular lung water following human brain death: implications for lung donor assessment and transplantation. Eur J Cardiothorac Surg 43:1227–32 Macdonald PS, Åneman A, Bhonagiri D, et al (2012) A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med 40:1635–44 Novitzky D, Mi Z, Sun Q, et al (2014) Thyroid Hormone Therapy in the Management of 63,593 Brain-Dead Organ Donors: A Retrospective Analysis. Transplantation 98:1119–27 Venkateswaran RV, Steeds RP, Quinn DW, et al (2009) The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J 30:1771–80 Nicolas-Robin A, Amour J, Ibanez-Esteve C, et al (2008) Effect of glucose-insulin-potassium in severe acute heart failure after brain death. Crit Care Med 36:2740–5 Myburgh JA, Mythen MG (2013) Resuscitation Fluids. N Engl J Med 369:1243–51 Reinhart K, Perner A, Sprung CL, et al (2012) Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 38:368–83 Guesde R, Barrou B, Leblanc I, et al (1998) Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 352:1178–118 Hébert PC, Wells G, Blajchman MA, et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–17 De Backer D, Biston P, Devriendt J, et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779–89 Schnuelle P, Gottmann U, Hoeger S, et al (2009) Effects of Donor Pretreatment With Dopamine on Graft Function After Kidney Transplantation: A Randomized Controlled Trial. JAMA 302:1067–75 Pinsard M, Ragot S, Mertes PM, et al (2014) Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care 18:R158 Dominguez-Roldan JM, Jimenez-Gonzalez PI, Garcia-Alfaro C, et al (2005) Electrolytic disorders, hyperosmolar states, and lactic acidosis in brain-dead patients. Transplantation Proc 37:1987–9 Salim A, Martin M, Brown C, et al (2006) The effect of a protocol of aggressive donor management: Implications for the national organ donor shortage. J Trauma 61:429–33 Patel MS, Zatarain J, La Cruz De S, et al (2014) The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup. JAMA Surg 149:969–75 Malinoski DJ, Patel MS, Daly MC, et al (2012) The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med 40:2773–80 Nijboer WN, Moers C, Leuvenink HG, Ploeg RJ (2011) How important is the duration of the brain death period for the outcome in kidney transplantation? Transpl Int 24:14–20 Inaba K, Branco BC, Lam L, et al (2010) Organ Donation and Time to Procurement: Late Is Not Too Late. J Trauma 68:1362–6 Guner M, Pirat A, Zeyneloglu P, et al (2007) Effect of the interval between organ donor brain death and organ harvesting on kidney graft function after transplantation. Transplantation Proc 39:837–41